Related references
Note: Only part of the references are listed.Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual
Keerthana Haridas et al.
NUTRITION (2020)
Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes
Tomas P. Griffin et al.
ENDOCRINE CONNECTIONS (2020)
CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype
Elisa De Paolis et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia
Arnaud Molin et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2019)
Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report
Aurelia Berthlet-Thomas et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
Daniele Cappellani et al.
CASE REPORTS IN ENDOCRINOLOGY (2019)
Optimal bone fracture repair requires 24R, 25-dihydroxyvitamin D3 and its effector molecule FAM57B2
Corine Martineau et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass (vol 45, pg 291, 2016)
Pietro Manuel Ferraro et al.
UROLITHIASIS (2017)
Genetic Diseases of Vitamin D Metabolizing Enzymes
Glenville Jones et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2017)
Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases
Ewa Pronicka et al.
JOURNAL OF APPLIED GENETICS (2017)
Hypercalcemic Disorders in Children
Victoria J. Stokes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)2D3 in Affected Patients
Martin Kaufmann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations
Colin Patrick Hawkes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations
Thomas O. Carpenter
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
Karl P. Schlingmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Peter J. Tebben et al.
ENDOCRINE REVIEWS (2016)
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets
Craig F. Munns et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Parathyroid hormone-ionized calcium dynamics over the first year of life
Atul K. Sharma et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2016)
Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia
Maddalena Gigante et al.
NEPHRON (2016)
Kidney Function and Influence of Sunlight Exposure in Patients With Impaired 24-Hydroxylation of Vitamin D Due to CYP24A1 Mutations
Marie-Lucile Figueres et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Calcium and bone homeostasis in heterozygous carrier's of CYP24A1 mutations: A cross-sectional study
M. Cools et al.
BONE (2015)
CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait
A. Molin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis
Tilman Jobst-Schwan et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake
Dganit Dinour et al.
PEDIATRIC NEPHROLOGY (2015)
Redefining normal bone and mineral clinical biochemistry reference intervals for healthy infants in Canada
Sina Gallo et al.
CLINICAL BIOCHEMISTRY (2014)
Ketotic Hypercalcemia: A Case Series and Description of a Novel Entity
Colin Patrick Hawkes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical Utility of Simultaneous Quantitation of 25-Hydroxyvitamin D and 24,25-Dihydroxyvitamin D by LC-MS/MS Involving Derivatization With DMEQ-TAD
Martin Kaufmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis
Galina Nesterova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Loss-of-Function Mutations of CYP24A1, the Vitamin D 24-Hydroxylase Gene, Cause Long-standing Hypercalciuric Nephrolithiasis and Nephrocalcinosis
Dganit Dinour et al.
JOURNAL OF UROLOGY (2013)
Hypercalcemia, Hypercalciuria, and Elevated Calcitriol Concentrations with Autosomal Dominant Transmission Due to CYP24A1 Mutations: Effects of Ketoconazole Therapy
Peter J. Tebben et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genetic Defect in CYP24A1, the Vitamin D 24-Hydroxylase Gene, in a Patient with Severe Infantile Hypercalcemia
Andrew Dauber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia
Karl P. Schlingmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pathophysiology of hypercalciuria in children
Tarak Srivastava et al.
PEDIATRIC NEPHROLOGY (2007)
Share Paper
